Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Sudeepta Aggarwal"'
Autor:
Megan N Landis, Stacy R Smith, Gabriel Berstein, Gerald Fetterly, Pranab Ghosh, Gang Feng, Vivek Pradhan, Sudeepta Aggarwal, Christopher Banfield, Elena Peeva, Michael S Vincent, Jean S Beebe, Sanela Tarabar
Publikováno v:
British Journal of Dermatology.
Background Plaque psoriasis (PsO) is an inflammatory skin disease driven, in part, by the activation of Janus kinase (JAK) signalling pathways. Objectives To assess the efficacy and safety of multiple doses of topical brepocitinib, a tyrosine kinase
Autor:
Albert M. Kim, Neeta B. Amin, Arthur Bergman, Roberto A. Calle, Theresa Tuthill, Kou Kou, Sudeepta Aggarwal, Naresh Aggarwal, Collin Crowley, Anthony Rinaldi, Santos Carvajal-Gonzalez, Veena Somayaji, Kendra K. Bence, Jessica Mancuso, Trenton T. Ross, Magalie Boucher, William P. Esler, Robert Dullea, Jeffrey A. Pfefferkorn, Małgorzata Inglot, Greg Tesz
Publikováno v:
Nature Medicine. 27:1836-1848
Alterations in lipid metabolism might contribute to the pathogenesis of non-alcoholic fatty liver disease (NAFLD). However, no pharmacological agents are currently approved in the United States or the European Union for the treatment of NAFLD. Two pa
Autor:
Megan N. Landis, Mark Arya, Stacy Smith, Zoe Draelos, Lisa Usdan, Sanela Tarabar, Vivek Pradhan, Sudeepta Aggarwal, Christopher Banfield, Elena Peeva, Michael S. Vincent, Vanja Sikirica, Jason Xenakis, Jean S. Beebe
Publikováno v:
The British journal of dermatologyReferences. 187(6)
Background Atopic dermatitis (AD) is a prevalent inflammatory, pruritic skin disease. The Janus kinase (JAK) pathway is a treatment target. Objectives To assess the efficacy, safety and pharmacokinetics of topical cream brepocitinib, a small-molecule
Autor:
Roberto Calle, Sudeepta Aggarwal, Jessica Mancuso, Arthur Bergman, Veena Somayaji, Trenton Ross, William Esler
Publikováno v:
Journal of Hepatology. 73:S455
Autor:
Mark R, Rigby, Linda A, DiMeglio, Marc S, Rendell, Eric I, Felner, Jean M, Dostou, Stephen E, Gitelman, Chetanbabu M, Patel, Kurt J, Griffin, Eva, Tsalikian, Peter A, Gottlieb, Carla J, Greenbaum, Nicole A, Sherry, Wayne V, Moore, Roshanak, Monzavi, Steven M, Willi, Philip, Raskin, Antoinette, Moran, William E, Russell, Ashley, Pinckney, Lynette, Keyes-Elstein, Michael, Howell, Sudeepta, Aggarwal, Noha, Lim, Deborah, Phippard, Gerald T, Nepom, James, McNamara, Mario R, Ehlers, Faith, Brendle
Publikováno v:
The lancet. Diabetes & endocrinology, vol 1, iss 4
Summary Background Type 1 diabetes results from autoimmune targeting of the pancreatic β cells, likely mediated by effector memory T (Tem) cells. CD2, a T cell surface protein highly expressed on Tem cells, is targeted by the fusion protein alefacep
Autor:
Stephen E, Gitelman, Peter A, Gottlieb, Mark R, Rigby, Eric I, Felner, Steven M, Willi, Lynda K, Fisher, Antoinette, Moran, Michael, Gottschalk, Wayne V, Moore, Ashley, Pinckney, Lynette, Keyes-Elstein, Sudeepta, Aggarwal, Deborah, Phippard, Peter H, Sayre, Linna, Ding, Jeffrey A, Bluestone, Mario R, Ehlers, Betty, Flores
Publikováno v:
Gitelman, SE; Gottlieb, PA; Rigby, MR; Felner, EI; Willi, SM; Fisher, LK; et al.(2013). Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial. The Lancet Diabetes and Endocrinology, 1(4), 306-316. doi: 10.1016/S2213-8587(13)70065-2. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/2sp5f6xx
Background: Type 1 diabetes results from T-cell-mediated destruction of β cells. Findings from preclinical studies and pilot clinical trials suggest that antithymocyte globulin (ATG) might be effective for reducing this autoimmune response. We asses
Autor:
G. Jonah Rainey, Valentina Ciccarone, Linda Jin, Sudeepta Aggarwal, Ezio Bonvini, Yinhua Yang, Wenjun Zhang, Paul A. Moore, Steve Burke, Syd Johnson, Sunan Zhang, Leilei He, Maria Concetta Veri, Scott Koenig, Kalpana Shah, Ling Huang, Sergey Gorlatov, Tengfei Zhang, Hua Li
Publikováno v:
Blood. 117:4542-4551
We describe the application of a novel, bispecific antibody platform termed dual affinity retargeting (DART) to eradicate B-cell lymphoma through coengagement of the B cell–specific antigen CD19 and the TCR/CD3 complex on effector T cells. Comparis
Autor:
Sudeepta Aggarwal, Brian Feild, Tao He, Deborah Mesmer, William Fitzhugh, Kim Rosenthal, Steven M. Ruben, Paul A. Moore, Jenny Heidbrink
Publikováno v:
Gynecologic Oncology. 115:430-437
Objective We have used mass-spectrometry (MS) based proteomics platform to identify cell surface proteins over-expressed on a cisplatin resistant derivative of an ovarian cancer cell line A2780. Methods Membrane associated glycoproteins from A2780 an
Autor:
James Lee, Susan Guillet, Guohua Pan, Jessica Foster, Katrina Nicholes, Peter Schow, Miko Maruoka, Weiguang Mao, Dorothy French, Sudeepta Aggarwal, Austin L. Gurney, Philip Risser
Publikováno v:
The Journal of Immunology. 167:6559-6567
IL-17 is a proinflammatory cytokine, and its in vivo expression induces neutrophilia in mice. IL-17E is a recently described member of an emerging family of IL-17-related cytokines. IL-17E has been shown to bind IL-17Rh1, a protein distantly related
Autor:
Jeremy Stinson, Zemin Zhang, Austin L. Gurney, Sudeepta Aggarwal, Wei-Hsien Ho, William I. Wood, Audrey Goddard, Ming-Hong Xie, Jessica Foster
Publikováno v:
Journal of Biological Chemistry. 275:31335-31339
We report the identification of a novel human cytokine, distantly related to interleukin (IL)-10, which we term IL-22. IL-22 is produced by activated T cells. IL-22 is a ligand for CRF2-4, a member of the class II cytokine receptor family. No high af